{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:09:56Z","timestamp":1790813396499,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jfma.2020.07.006","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T08:27:51Z","timestamp":1594283271000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"P1","title":["Non-alcoholic fatty liver disease: A review with clinical and pathological correlation"],"prefix":"10.1016","volume":"120","author":[{"given":"Yen-Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jfma.2020.07.006_bib3","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s10620-016-4143-0","article-title":"Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations","volume":"61","author":"Sherif","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41575-018-0055-0","article-title":"The changing epidemiology of liver diseases in the Asia\u2013Pacific region","volume":"16","author":"Wong","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jfma.2020.07.006_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00004836-200609000-00016","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults","volume":"40","author":"Chen","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jfma.2019.03.014","article-title":"Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis","volume":"119","author":"Huang","year":"2020","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jpeds.2012.08.043","article-title":"Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988\u20131994 to 2007\u20132010","volume":"162","author":"Welsh","year":"2013","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.jfma.2020.07.006_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jpeds.2014.04.019","article-title":"Predicting hepatic steatosis in a racially and ethnically diverse cohort of adolescent girls","volume":"165","author":"Rehm","year":"2014","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American society of pediatric gastroenterology, Hepatology and Nu","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.jfma.2020.07.006_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.jfma.2020.07.006_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12565","article-title":"Association of histologic disease activity with progression of nonalcoholic fatty liver disease","volume":"2","author":"Kleiner","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"43","key":"10.1016\/j.jfma.2020.07.006_bib14","doi-asserted-by":"crossref","first-page":"37085","DOI":"10.1074\/jbc.M111.290114","article-title":"Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease","volume":"286","author":"Huang","year":"2011","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.jfma.2020.07.006_bib15","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ajg.2013.476","article-title":"The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis","volume":"109","author":"Singal","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jfma.2020.07.006_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jfma.2020.07.006_bib18","first-page":"1","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jfma.2020.07.006_bib19","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0087523","article-title":"Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease","volume":"9","author":"Petta","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jfma.2020.07.006_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.humpath.2016.01.001","article-title":"Acidophil bodies in nonalcoholic steatohepatitis","volume":"52","author":"Yeh","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jfma.2020.07.006_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.anndiagpath.2018.09.009","article-title":"Nonalcoholic fatty liver disease (NAFLD): diagnosis, pitfalls, and staging","volume":"37","author":"Koch","year":"2018","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cld.2004.04.009","article-title":"Mitochondria in nonalcoholic fatty liver disease","volume":"8","author":"Caldwell","year":"2004","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.jfma.2020.07.006_bib24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.20202","article-title":"The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis","volume":"39","author":"Le","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/jhep.2002.33892","article-title":"HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity","volume":"36","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.20023","article-title":"Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver","volume":"39","author":"Bugianesi","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep.24038","article-title":"Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease","volume":"53","author":"Nelson","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1053\/j.gastro.2009.11.013","article-title":"HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"138","author":"Valenti","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.20842","article-title":"Histopathology of pediatric nonalcoholic fatty liver disease","volume":"42","author":"Schwimmer","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.21262","article-title":"NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice","volume":"44","author":"Nobili","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jfma.2020.07.006_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/hep.23133","article-title":"Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study","volume":"50","author":"Carter-Kent","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jfma.2020.07.006_bib32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2008.01.026","article-title":"Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis","volume":"48","author":"Lackner","year":"2008","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jhep.2010.11.021","article-title":"Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease","volume":"55","author":"Tandra","year":"2011","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.22724","article-title":"Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD\u2014clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network","volume":"49","author":"Brunt","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1089-3261(02)00002-8","article-title":"Alcoholic and nonalcoholic steatohepatitis","volume":"6","author":"Brunt","year":"2002","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.hepres.2005.09.016","article-title":"Histological study on comparison between NASH and ALD","volume":"33","author":"Nakano","year":"2005","journal-title":"Hepatol Res"},{"issue":"5","key":"10.1016\/j.jfma.2020.07.006_bib37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1309\/RTPM1PY6YGBL2G2R","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"128","author":"Yeh","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.jfma.2020.07.006_bib38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1309\/1PX2LMPQUH1EE12U","article-title":"The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens","volume":"123","author":"Sanderson","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.jfma.2020.07.006_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms17060803","article-title":"NAFLD and NASH in HCV infection: prevalence and significance in hepatic and extrahepatic manifestations","volume":"17","author":"Adinolfi","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","article-title":"Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3","volume":"33","author":"Rubbia-Brandt","year":"2000","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12072-011-9277-8","article-title":"Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network","volume":"6","author":"Vuppalanchi","year":"2012","journal-title":"Hepatol Int"},{"issue":"11","key":"10.1016\/j.jfma.2020.07.006_bib42","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1872-034X.2007.00150.x","article-title":"Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis","volume":"37","author":"Niwa","year":"2007","journal-title":"Hepatol Res"},{"issue":"7","key":"10.1016\/j.jfma.2020.07.006_bib43","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jfma.2020.07.006_bib44","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/00000478-199912000-00001","article-title":"Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms","volume":"23","author":"Nguyen","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/PAS.0000000000000781","article-title":"Steatohepatitis-like changes in focal nodular hyperplasia, A finding to distinguish from steatohepatitic variant of hepatocellular carcinoma","volume":"41","author":"Deniz","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","article-title":"Genotype\u2013phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC","volume":"43","author":"Zucman-Rossi","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib47","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.21743","article-title":"Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry","volume":"46","author":"Bioulac-Sage","year":"2007","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jfma.2020.07.006_bib48","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0b013e3181f31caa","article-title":"Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD\/NASH","volume":"34","author":"Salomao","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.jfma.2020.07.006_bib49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.humpath.2011.07.005","article-title":"The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis","volume":"43","author":"Salomao","year":"2012","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.jfma.2020.07.006_bib50","doi-asserted-by":"crossref","first-page":"961","DOI":"10.5858\/arpa.2012-0048-OA","article-title":"Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India","volume":"137","author":"Jain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.jfma.2020.07.006_bib51","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.humpath.2015.07.018","article-title":"Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study","volume":"46","author":"Yeh","year":"2015","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.jfma.2020.07.006_bib52","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jfma.2020.07.006_bib53","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/PAS.0b013e3182495c73","article-title":"Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma","volume":"36","author":"Singhi","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.jfma.2020.07.006_bib54","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jfma.2020.07.006_bib55","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib56","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"(CRN)NCRN. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jfma.2020.07.006_bib57","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib58","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/apt.12569","article-title":"Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease \u2013 the role of transient elastography and plasma cytokeratin-18 fragments","volume":"39","author":"Kwok","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.jfma.2020.07.006_bib59","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease: current evidence and practice","volume":"25","author":"Zhou","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jfma.2020.07.006_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH \u2014 current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib61","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2017.11.028","article-title":"Role of imaging-based biomarkers in NAFLD: recent advances in clinical application and future research directions","volume":"68","author":"Loomba","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib62","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography","volume":"150","author":"Imajo","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jfma.2020.07.006_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2013.07.012","article-title":"Drug-induced steatohepatitis","volume":"17","author":"Patel","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.jfma.2020.07.006_bib64","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.humpath.2011.07.008","article-title":"Total parenteral nutrition therapy and liver injury: a histopathologic study with clinical correlation","volume":"43","author":"Naini","year":"2012","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib65","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-0032-1316471","article-title":"Nonalcoholic fatty liver disease and HIV infection","volume":"32","author":"Vallet-Pichard","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0032-1306421","article-title":"Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research","volume":"32","author":"Kleiner","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"11","key":"10.1016\/j.jfma.2020.07.006_bib67","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/ibd\/izz043","article-title":"Systematic review with meta-analysis: epidemiology of nonalcoholic fatty liver disease in patients with inflammatory bowel disease","volume":"25","author":"Zou","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.jfma.2020.07.006_bib68","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/MEG.0000000000001144","article-title":"Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysis","volume":"30","author":"Lapumnuaypol","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41419-017-0124-2","article-title":"Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease","volume":"9","author":"Sartini","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jfma.2020.07.006_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2017.09.008","article-title":"Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease","volume":"69","author":"Bosch","year":"2017","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.jfma.2020.07.006_bib71","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jhep.2015.01.013","article-title":"Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease","volume":"62","author":"Reilly","year":"2015","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jfma.2020.07.006_bib72","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/apt.14910","article-title":"Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors","volume":"48","author":"Tovoli","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000150","article-title":"Clinicopathological and immunological characteristics and outcome of concomitant coeliac disease and non-alcoholic fatty liver disease in adults: a large prospective longitudinal study","volume":"5","author":"Kamal","year":"2018","journal-title":"BMJ open Gastroenterol"},{"issue":"6","key":"10.1016\/j.jfma.2020.07.006_bib74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.semdp.2019.07.008","article-title":"Wilson disease","volume":"36","author":"Guindi","year":"2019","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib75","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.20092","article-title":"Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial","volume":"39","author":"Lindor","year":"2004","journal-title":"Hepatology"},{"issue":"9972","key":"10.1016\/j.jfma.2020.07.006_bib76","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review","volume":"56","author":"Thoma","year":"2012","journal-title":"J Hepatol"},{"issue":"18","key":"10.1016\/j.jfma.2020.07.006_bib78","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, Vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jfma.2020.07.006_bib79","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","article-title":"Vitamin E and Vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib80","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/j.gastro.2009.04.052","article-title":"Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease","volume":"137","author":"Mathurin","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib81","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.21661","article-title":"The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis","volume":"46","author":"Lutchman","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jfma.2020.07.006_bib82","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/jlts.2001.23011","article-title":"Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis","volume":"7","author":"Contos","year":"2001","journal-title":"Liver Transplant"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib83","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ajg.2009.717","article-title":"Non-alcoholic fatty liver disease in liver transplant recipients: another story of \u201cseed and soil\u201d","volume":"105","author":"Dumortier","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jfma.2020.07.006_bib84","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/TP.0b013e31820b6b84","article-title":"NAFLD recurrence in liver transplant recipients","volume":"91","author":"Dureja","year":"2011","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib85","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/lt.25338","article-title":"Predictors of de novo nonalcoholic fatty liver disease after liver transplantation and associated fibrosis","volume":"25","author":"Galvin","year":"2019","journal-title":"Liver Transplant"},{"issue":"2","key":"10.1016\/j.jfma.2020.07.006_bib86","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jfma.2020.07.006_bib87","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0168-8278(00)80397-9","article-title":"Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis","volume":"32","author":"Masseroli","year":"2000","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jfma.2020.07.006_bib88","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cyto.b.21790","article-title":"A novel automatic digital algorithm that accurately quantifies steatosis in NAFLD on histopathological whole-slide images","volume":"96","author":"Munsterman","year":"2019","journal-title":"Cytom Part B Clin Cytom"},{"issue":"6","key":"10.1016\/j.jfma.2020.07.006_bib89","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ajcp\/aqx104","article-title":"Second harmonic generation reveals subtle fibrosis differences in adult and pediatric nonalcoholic fatty liver disease","volume":"148","author":"Liu","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.jfma.2020.07.006_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-34300-2","article-title":"Deep learning enables automated scoring of liver fibrosis stages","volume":"8","author":"Yu","year":"2018","journal-title":"Sci Rep"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620302953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620302953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:44:39Z","timestamp":1760539479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664620302953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0929664620302953"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2020.07.006","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease: A review with clinical and pathological correlation","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2020.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}